These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8942941

  • 21. Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry.
    Ferreira A, Saraiva M, Behets G, Macedo A, Galvão M, D'Haese P, Drüeke TB.
    J Nephrol; 2009; 22(6):783-93. PubMed ID: 19967658
    [Abstract] [Full Text] [Related]

  • 22. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N.
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [Abstract] [Full Text] [Related]

  • 23. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
    Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, Shoji T, Ishimura E, Ohta T, Nakatani T, Kim M, Nishizawa Y.
    Am J Kidney Dis; 2002 Jun; 39(6):1261-9. PubMed ID: 12046040
    [Abstract] [Full Text] [Related]

  • 24. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H, Koiwa F, Shishido K, Takahashi K, Ito H, Kinugasa E, Taguchi S.
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [Abstract] [Full Text] [Related]

  • 25. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E, Beşbaş N, Saatçi U, Hasçelik G, Topaloğlu R, Ozen S, Bakkaloğlu A.
    Turk J Pediatr; 2004 Jun; 46(1):28-31. PubMed ID: 15074371
    [Abstract] [Full Text] [Related]

  • 26. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z, Konieczna M, Wańkowicz Z.
    Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
    [Abstract] [Full Text] [Related]

  • 27. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K, Perrea D, Doumouchtsis S, Tziamalis M, Poulakou M, Vlachos I, Kostakis A.
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [Abstract] [Full Text] [Related]

  • 28. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T, Garzoni D, Staub T, Binet I, Wüthrich RP.
    Kidney Blood Press Res; 2006 Feb; 29(3):175-81. PubMed ID: 16931896
    [Abstract] [Full Text] [Related]

  • 29. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population.
    Couttenye MM, D'Haese PC, Deng JT, Van Hoof VO, Verpooten GA, De Broe ME.
    Nephrol Dial Transplant; 1997 Oct; 12(10):2144-50. PubMed ID: 9351080
    [Abstract] [Full Text] [Related]

  • 30. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H, Esser A, Roth HJ, Schmidt-Gayk H.
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [Abstract] [Full Text] [Related]

  • 31. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K.
    Nephron; 1996 Apr; 74(1):89-103. PubMed ID: 8883025
    [Abstract] [Full Text] [Related]

  • 32. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients.
    Couttenye MM, D'Haese PC, Van Hoof VO, Lemoniatou E, Goodman W, Verpooten GA, De Broe ME.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1065-72. PubMed ID: 8671970
    [Abstract] [Full Text] [Related]

  • 33. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y, Ding F, Chen N, Mei CL, Qian JQ, Wang XY, Shi W, Hou FF, Li XW, Wang M, Chen YP.
    Ren Fail; 2005 Jun; 27(2):205-12. PubMed ID: 15807187
    [Abstract] [Full Text] [Related]

  • 34. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H, Pańiczyk-Tomaszewska M, Debiński A, Polowiec Z, Sawicki A, Sieniawska M.
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [Abstract] [Full Text] [Related]

  • 35. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
    Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC.
    Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
    [Abstract] [Full Text] [Related]

  • 36. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 May; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 37. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
    Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D, Ballanti P, Bonucci E.
    Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
    [Abstract] [Full Text] [Related]

  • 38. Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers.
    Montalbán C, García-Unzueta MT, De Francisco AL, Amado JA.
    Horm Metab Res; 1999 Jan; 31(1):14-7. PubMed ID: 10077343
    [Abstract] [Full Text] [Related]

  • 39. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jan; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 40. Biochemical indices of renal osteodystrophy in dialysis patients on the island of Malta.
    Galea I, Farrugia E.
    Int Urol Nephrol; 2005 Jan; 37(2):335-40. PubMed ID: 16142567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.